Dermata Therapeutics shares jump 10.27% after-hours as company unveils new brand name for OTC skincare business.

Dermata Therapeutics surged 10.27% in after-hours trading following the announcement that it will reveal its new brand name for its over-the-counter skincare business, signaling a strategic shift toward a more direct-to-consumer approach. The rebranding initiative reflects the company’s focus on streamlining its skincare offerings and enhancing market visibility, which investors interpreted as a positive step for future growth. The move aligns with broader industry trends favoring direct engagement with consumers, potentially improving brand recognition and market share in the competitive OTC skincare sector.